MENU
+Compare
EDGE
ETF ticker: BATS
AS OF
Jun 27 closing price
Price
$39.73
Change
+$0.33 (+0.84%)

EDGE stock forecast, quote, news & analysis

The investment seeks capital appreciation... Show more

Category: #Trading
EDGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for EDGE with price predictions
Jun 27, 2025

EDGE's RSI Indicator stays in overbought zone for 1 day

Watch for a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

EDGE broke above its upper Bollinger Band on June 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 06, 2025. You may want to consider a long position or call options on EDGE as a result. In of 5 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EDGE just turned positive on June 27, 2025. Looking at past instances where EDGE's MACD turned positive, the stock continued to rise in of 2 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDGE advanced for three days, in of 15 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 7 cases where EDGE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Industry description

The investment seeks capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities and derivative instruments that provide exposure to equity securities. To gain this exposure, the fund will primarily invest in one or more ETFs or options on an ETF or index (each, a “reference asset”). The fund is non-diversified.
View a ticker or compare two or three
EDGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of linical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Category Trading

Profile
Fundamentals
Details